Table 4.
COVID-19 diagnostics and baseline reported clinical symptoms of patients in the treatment group
| Clinical symptom [n (%)] | Risk-stratified group |
All patients (N = 141) | ||
|---|---|---|---|---|
| Group (N = 69) | Group B (N = 48) | Group C (N = 24) | ||
| Cough/dry cough | 60 (87) | 39 (81) | 24 (100) | 123 (87) |
| Fever | 53 (77) | 38 (79) | 18 (75) | 109 (77) |
| Shortness of breath | 17 (25) | 48 (100) | 0 (0) | 65 (46) |
| Changes to or no smell or taste | 21 (30) | 19 (40) | 2 (8) | 42 (30) |
| Sore throat | 19 (28) | 8 (17) | 7 (29) | 34 (24) |
| Headache | 19 (28) | 6 (13) | 7 (29) | 32 (23) |
| Runny nose/clear rhinorrhoea | 16 (23) | 8 (17) | 4 (17) | 28 (20) |
| Sinus congestion | 10 (15) | 9 (19) | 4 (17) | 23 (16) |
| Diarrhoea/vomiting | 1 (2) | 5 (10) | 1 (4) | 7 (5) |
| Cold symptoms | 31 (45) | 16 (33) | 12 (50) | 59 (42) |
| Feels sick | 40 (58) | 38 (79) | 17 (71) | 95 (67) |
| Weakness | 44 (64) | 22 (46) | 11 (46) | 77 (55) |
| Low back pain | 3 (4) | 0 (0) | 1 (4) | 4 (3) |
COVID-19, coronavirus disease 2019.